B Sipos

Summary

Country: Germany

Publications

  1. ncbi request reprint pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104
    Steffen Ormanns
    Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig Maximilians University of Munich, Munchen, Germany
    BMC Cancer 14:624. 2014
  2. ncbi request reprint [Will molecular diagnostics become established in pancreatic pathology?]
    B Sipos
    Allgemeine Pathologie und Pathologische Anatomie, Institut für Pathologie und Neuropathologie, Universitatsklinikum Tubingen, Liebermeisterstr 8, 72076, Tubingen, Deutschland
    Pathologe 34:214-20. 2013
  3. pmc Adenocarcinoma arising in a cystic duplication of the small bowel: case report and review of literature
    Gregor Blank
    Department of General, Visceral and Transplant Surgery, University of Tubingen, Hoppe Seyler Strasse 3, D 72076 Tubingen, Germany
    World J Surg Oncol 10:55. 2012
  4. ncbi request reprint [Precursor lesions of pancreatobiliary cancer]
    B Sipos
    Abt Allg Pathologie und Pathologische Anatomie, Institut für Pathologie und Neuropathologie, Universitatsklinikum Tubingen, Liebermeisterstr 8, 72076, Tubingen, Deutschland
    Pathologe 32:224-31. 2011
  5. ncbi request reprint Establishment of robust controls for the normalization of miRNA expression in neuroendocrine tumors of the ileum and pancreas
    J Sperveslage
    Institute of Pathology, University of Tubingen, Liebermeisterstr 8, 72076, Tubingen, Germany
    Endocrine 46:226-30. 2014

Collaborators

  • G Kloppel
  • Steffen Ormanns
  • J Sperveslage
  • Gregor Blank
  • Ursula Vehling-Kaiser
  • Stephan Krüger
  • M Hoffmeister
  • Stefan Boeck
  • Thomas Kirchner
  • Michael Haas
  • Ludwig Fischer von Weikersthal
  • Tim F Greten
  • Thomas C Gauler
  • T Henopp
  • Andreas Jung
  • Volker Heinemann
  • Cornelia Winkelmann
  • Rüdiger P Laubender
  • Irene Esposito
  • Anna Melissa Schlitter
  • Michael Geissler
  • Jens T Siveke
  • Angela Marten
  • Michael R Clemens
  • Ruth Ladurner
  • Alfred Konigsrainer

Detail Information

Publications5

  1. ncbi request reprint pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104
    Steffen Ormanns
    Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig Maximilians University of Munich, Munchen, Germany
    BMC Cancer 14:624. 2014
    ..The role of pERK, pAKT and p53 as biomarkers in patients with advanced pancreatic cancer has not yet been defined...
  2. ncbi request reprint [Will molecular diagnostics become established in pancreatic pathology?]
    B Sipos
    Allgemeine Pathologie und Pathologische Anatomie, Institut für Pathologie und Neuropathologie, Universitatsklinikum Tubingen, Liebermeisterstr 8, 72076, Tubingen, Deutschland
    Pathologe 34:214-20. 2013
    ..Hopefully these results will contribute to prognostic and therapeutic stratification of PDAC and to a reliable preoperative diagnostics of benign cystic pancreatic tumors in the future. ..
  3. pmc Adenocarcinoma arising in a cystic duplication of the small bowel: case report and review of literature
    Gregor Blank
    Department of General, Visceral and Transplant Surgery, University of Tubingen, Hoppe Seyler Strasse 3, D 72076 Tubingen, Germany
    World J Surg Oncol 10:55. 2012
    ..Here we report a unique case of an adenocarcinoma arising in a coincidentally found cystic duplication of the small bowel...
  4. ncbi request reprint [Precursor lesions of pancreatobiliary cancer]
    B Sipos
    Abt Allg Pathologie und Pathologische Anatomie, Institut für Pathologie und Neuropathologie, Universitatsklinikum Tubingen, Liebermeisterstr 8, 72076, Tubingen, Deutschland
    Pathologe 32:224-31. 2011
    ..Despite well defined morphological features in BilIN, the molecular alterations seen during early tumor progression in the biliary tract are poorly understood...
  5. ncbi request reprint Establishment of robust controls for the normalization of miRNA expression in neuroendocrine tumors of the ileum and pancreas
    J Sperveslage
    Institute of Pathology, University of Tubingen, Liebermeisterstr 8, 72076, Tubingen, Germany
    Endocrine 46:226-30. 2014
    ..The determination of SNORD61 and SNORD95 for ileal NETs and SNORD95 and miR-93 for pancreatic NETs as good normalizers presents a useful tool for experiments involving the analysis of miRNA expression...